Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of Ligand Pharmaceuticals stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $84.54, for a total value of $290,817.60. Following the sale, the insider now directly owns 100,421 shares in […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $84.54, for a total transaction of $290,817.60. Following the sale, the insider now directly owns 100,421 shares of the company’s […]
Ligand Pharmaceuticals (NASDAQ:LGND) Releases Earnings Results, Beats Expectations By $3.01 EPS modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats Estimates By $3.01 EPS etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.